Inflammatory responses in Ebola virus-infected patients.
about
Animal models for Ebola and Marburg virus infectionsHuman fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosisClinical management of filovirus-infected patientsIntracellular events and cell fate in filovirus infectionFilovirus research in Gabon and equatorial Africa: the experience of a research center in the heart of AfricaQuantifying Poverty as a Driver of Ebola TransmissionPyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cellsEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbola haemorrhagic feverTyro3 family-mediated cell entry of Ebola and Marburg virusesEbola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cellsGene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Crimean-Congo hemorrhagic fever (CCHF) in Southern KordofanClinical development of Ebola vaccinesThe Role of Cytokines and Chemokines in Filovirus InfectionFiloviruses: One of These Things is (not) Like the OtherAddressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal SepsisEbola: a holistic approach is required to achieve effective management and controlMouse models for filovirus infections[Haemostasis dysregulation in filovirus infections].Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivityNeglected filovirusesInterferon-γ Inhibits Ebola Virus InfectionEvaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.Broad-Range Antiviral Activity of Hydrogen Sulfide Against Highly Pathogenic RNA VirusesImmunosuppression abrogates resistance of young rabbits to Rabbit Haemorrhagic Disease (RHD)Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, GuineaSeeking Clearer Recommendations for Hand Hygiene in Communities Facing Ebola: A Randomized Trial Investigating the Impact of Six Handwashing Methods on Skin Irritation and DermatitisProgress towards the treatment of Ebola haemorrhagic fever.Insights from clinical research completed during the west Africa Ebola virus disease epidemic.Ebola: Implications and Perspectives.Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome.The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge.Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virusRole of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophagesTacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages.Effects of Ebola virus glycoproteins on endothelial cell activation and barrier functionInteracting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression.
P2860
Q21131118-DED52159-4EE6-4906-B67D-FAE002BBA203Q21144780-24D0CB75-9054-42EC-A358-FA1748025F81Q22305518-4623554B-A39C-4933-8133-C7466E3D91AEQ22305521-DDB8399B-CC8F-474D-9D4A-8A51D2E78FA0Q24273305-1081C16E-8256-4626-A812-6E931B968C68Q24290713-801E24AC-C90F-42E6-8BCD-9A4081A9C59FQ24562099-47DFCABB-ABBC-40AE-A13A-4049AD114790Q24597625-8E2E4F19-BF65-4283-B457-AE7A7A5AB8DCQ24629338-345A5C72-92EE-408E-A963-5CE928C8FA64Q24670567-AF547555-F569-4D64-AC95-25428FFA1694Q24794365-52652711-83E3-4F89-83BD-4C1116528507Q25256700-F307AA60-1225-4818-BC6E-3B29B0565710Q26700150-84B53653-FD87-4985-B7F4-154355C00BF0Q26775792-02597B4E-33E4-4420-AFE2-F0D71FF461BAQ26778003-F302A873-F2BF-441E-9ED0-E46487D5326FQ26783063-E783D1A5-EA8C-46C4-9561-12A416465DBEQ26783097-24132C03-47EA-48A2-A4AB-22107132C26DQ26823792-D7627653-98B3-4268-A4BB-065CDFCDCB6AQ27011569-9954A8A9-944A-40DE-953A-4F5569136EA0Q27691452-3B38CF3B-ABE5-4D93-AF75-6C5878730599Q28066142-2229FD4E-5739-4DA0-B943-E6A920FEAF60Q28383265-4208B36F-118E-4F6E-840E-858D3FEE8066Q28550929-704D499E-0C7C-424A-AE68-154D908338EAQ28554599-A70AB34F-ED09-45F1-834D-41994595A0CEQ28582806-7748631D-813E-425A-8D0B-3059415A6278Q28972246-816AB89F-A8D8-48A2-9732-1043E1156C69Q29247868-68050244-74CC-41E9-ADE6-5D0DE06A4EB6Q29248412-57DA4A83-A47F-41E6-91C3-1B654870D166Q30230272-FB1D8982-D82B-48FC-91E9-0B3C9768DC65Q30234590-4E0F7D05-7C7F-4B58-9F60-B1E99A7CEFCCQ30378672-EE1E25FD-D979-48FC-8F90-4FA96D433FCEQ33362611-A31F289A-DC69-43A1-96F5-0ACB2EE3E8B7Q33398602-699AE485-DCA2-4384-A625-C50598EEC159Q33603827-787D1D95-C91B-444F-9D0A-8FC0EB860041Q33733844-52071247-4865-4C40-9956-5859E7A7F183Q33781224-03C18159-B3E6-4A07-988B-992AE121A4ADQ33900301-E7C435DF-B735-45F6-B4E6-26D123BAE741Q33912033-A9A9C2E3-F699-4B5E-895D-39A94AF524C9Q33962671-4163F5B6-4236-4473-98EA-69713207CCFDQ34058804-A35FB128-F6E6-41DE-9EB0-0A1E10F6A094
P2860
Inflammatory responses in Ebola virus-infected patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Inflammatory responses in Ebola virus-infected patients.
@en
type
label
Inflammatory responses in Ebola virus-infected patients.
@en
prefLabel
Inflammatory responses in Ebola virus-infected patients.
@en
P2093
P2860
P1476
Inflammatory responses in Ebola virus-infected patients
@en
P2093
A J Georges
E Mavoungou
I Bedjabaga
J Lansoud-Soukate
M-C Georges-Courbot
P2860
P304
P356
10.1046/J.1365-2249.2002.01800.X
P577
2002-04-01T00:00:00Z